Scientists track Long-Term effects of common bowel disease treatment
NCT ID NCT02808780
Summary
This study is observing adults with moderate-to-severe ulcerative colitis who are already taking either Simponi or thiopurine medications. Researchers are tracking side effects, hospital visits, and how the disease affects daily life and work over time. The goal is to better understand the long-term safety and real-world impact of these treatments, not to test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Murrieta, California, United States
-
Study site
Rialto, California, United States
-
Study site
Ventura, California, United States
-
Study site
Coral Gables, Florida, United States
-
Study site
Fort Myers, Florida, United States
-
Study site
Lake Worth, Florida, United States
-
Study site
Lauderdale Lakes, Florida, United States
-
Study site
Miami, Florida, United States
-
Study site
Tampa, Florida, United States
-
Study site
Suwanee, Georgia, United States
-
Study site
Chicago, Illinois, United States
-
Study site
Sylvania, Ohio, United States
-
Study site
Pittsburgh, Pennsylvania, United States
-
Study site
Houston, Texas, United States
-
Study site
San Antonio, Texas, United States
-
Study site
Lansdowne Town Center, Virginia, United States
-
Study site
Salzburg, Austria
-
Study site
Sankt Poelten Noe, Austria
-
Study site
Vienna, Austria
-
Study site
New Westminster, British Columbia, Canada
-
Study site
Vancouver, British Columbia, Canada
-
Study site
Oshawa, Ontario, Canada
-
Study site
Ottawa, Ontario, Canada
-
Study site
Pilsen, Czechia
-
Study site
Clermont-Ferrand, France
-
Study site
Clichy, France
-
Study site
Créteil, France
-
Study site
Grenoble, France
-
Study site
Montpellier, France
-
Study site
Nice, France
-
Study site
Pierre-Bénite, France
-
Study site
Saint-Priest-en-Jarez, France
-
Study site
Strasbourg, France
-
Study site
Berlin, Germany
-
Study site
Dessau Roblau, Germany
-
Study site
Halle, Germany
-
Study site
Hamburg, Germany
-
Study site
Heidelberg, Germany
-
Study site
Kiel, Germany
-
Study site
Leipzig, Germany
-
Study site
Ludwigshafen, Germany
-
Study site
Lyneburg, Germany
-
Study site
München, Germany
-
Study site
Saarbrücken, Germany
-
Study site
Athens, Greece
-
Study site
Heraklion, Greece
-
Study site
Ioannina, Greece
-
Study site
Thessaloniki, Greece
-
Study site
Busan, South Korea
-
Study site
Gyeonggi-do, South Korea
-
Study site
Seongnam-si, South Korea
-
Study site
Seoul, South Korea
-
Study site
A Coruña, Spain
-
Study site
Barcelona, Spain
-
Study site
Córdoba, Spain
-
Study site
Fuenlabrada, Spain
-
Study site
Huelva, Spain
-
Study site
Madrid, Spain
-
Study site
Majadahonda, Spain
-
Study site
San Sebastián de los Reyes, Spain
-
Study site
Valencia, Spain
-
Study site
Vigo, Spain
-
Study site
Zaragoza, Spain
Conditions
Explore the condition pages connected to this study.